Reached Settlement for Plaintiff in Patent Case Against Eli Lilly and ImClone Related to Cancer Drug
June 28, 2022
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA v. ELI LILLY et al, 2:15-cv- 06133 (E.D. Pa.)
Robins Kaplan LLP represented the Trustees of the University of Pennsylvania in a complex patent infringement matter against Eli Lilly and ImClone related to the manufacture and sale of Erbitux, a blockbuster cancer drug. Penn asserted a claim of patent infringement for methods of treating cancer with the Defendants’ drug Erbitux followed by radiation. Erbitux is an antibody to EGFR. The case was resolved on confidential terms before trial.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.